Population characteristics, healthcare pathways and outcomes of patients with cirrhosis hospitalized with overt hepatic encephalopathy in France: A study of the French Hospital-Discharge Database [0.03%]
法国住院数据库中肝硬化患者出现显性肝性脑病的人口特征、医疗途径和结果：一项法国出院数据库研究
Dominique Thabut,Julia Roux,Philippe Sultanik et al.
Dominique Thabut et al.
Hepatic encephalopathy (HE) is a severe complication of cirrhosis, independently associated with a poor survival. The objectives of this study were to describe the prevalence of overt hepatic encephalopathy (OHE) requiring hospitalization, ...
The regulatory effect of lncRNA LINC00943 on the progression of hepatocellular carcinoma and its relationship with clinicopathological features [0.03%]
长链非编码RNA LINC00943对肝细胞癌进程的调控作用及其与临床病理特征的关系
Xiaoan Qi,Liang Liu
Xiaoan Qi
Background: The risk factors for the pathogenesis of HCC are highly variable, and the prognosis of patients is very unsatisfactory. In this study, we investigated the regulatory effect of LINC00943 on HCC progression and ...
Gut dysbiosis in Crohn's disease: Never so close to solving the chicken-and-egg enigma: Commentary to "Gut microbiome composition is associated with future onset of Crohn's disease in healthy first-degree relatives, by Raygoza Garay JA et al., Gastroenterology 2023" [0.03%]
克罗恩病中的肠道菌群失调：距离破解鸡与蛋的谜题从未如此接近：对Raygoza Garay JA等人的"Gastroenterology 2023"文章《肠道微生物组的组成与健康的一级亲属未来发生克罗恩病的相关性》的评论
Nathan Grellier,Harry Sokol,Philippe Seksik
Nathan Grellier
Crohn's disease (CD) is a chronic disease of the digestive tract whose pathogenesis remains not fully understood. Several studies have implicated the gut microbiota as a key player in the onset of gut inflammation. However, most of the data...
Metabolism-related signalling pathways involved in the pathogenesis and development of metabolic dysfunction-associated steatotic liver disease [0.03%]
与代谢功能障碍相关的脂肪性肝病发病和进展有关的信号通路研究
Cheng Xie,Kaiyu Liu,Yixin Xie et al.
Cheng Xie et al.
Metabolic dysfunction-associated steatotic liver disease (MASLD) which formerly known as non-alcoholic fatty liver disease (NAFLD) is one of the causes of liver cirrhosis. Currently, a growing number of liver cirrhosis cases develop on the ...
Reply to "Epidemiology, treatment and burden of Wilson disease in France: A 10-year analysis of the National health insurance database" [0.03%]
对“法国威尔森病的流行病学、治疗和负担：全国健康保险数据库10年分析”的答复
Mickael Alexandre Obadia,France Woimant,Philippe Tuppin et al.
Mickael Alexandre Obadia et al.
Good outcome of liver transplantation in patients with pre-existing renal cell carcinoma [0.03%]
肝移植前即存在的肾细胞癌患者的预后良好
G Lassailly,M Ningarhari,J Dumortier et al.
G Lassailly et al.
The presence of a pre-existing or recent extra-hepatic solid tumor was considered for a long time as an absolute contraindication to liver transplantation, by fear of futility with an unacceptable increase in non-liver-related mortality. Ho...
Cardiovascular outcomes post bariatric surgery in patients with metabolic dysfunction-associated steatotic liver disease - A systematic review and meta-analysis [0.03%]
代谢性功能障碍相关肝脂肪变性疾病患者接受代谢手术后的远期心血管结局：系统评价和Meta分析
Jai Kumar,Sana Mohsin,Misha Hasan et al.
Jai Kumar et al.
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD), is linked with an increased risk of adverse cardiovascular events. Studies have ...
Paneth cell: The missing link between obesity, MASH and portal hypertension [0.03%]
肥胖、MASH与门脉高压之间的缺失环节—潘氏细胞
Minu Sajeev Kumar
Minu Sajeev Kumar
Obesity is a global health crisis, with its prevalence steadily rising over the past few decades. One concerning consequence of obesity is its association with metabolic associated steatohepatitis [MASH], portal hypertension and liver cirrh...
Yongwei Xu,Yan Song,Bacui Zhang et al.
Yongwei Xu et al.
Sustained response and HBsAg loss after nucleo(s)tide analogue discontinuation in chronic hepatitis B patients: the prospective SNAP study [0.03%]
慢性乙型肝炎患者核苷(酸)类似物停药后的持续应答和乙肝表面抗原清除：SNAP研究
Sylvia M Brakenhoff,Mark Claassen,Pieter Honkoop et al.
Sylvia M Brakenhoff et al.
Background & aim(s): Current guidelines suggest that nucleos(t)ide analogues (NA) can be discontinued before HBsAg loss in a selected group of chronic hepatitis B (CHB) patients. We aimed to study the safety and off-treat...